News | News By Subject | News by Disease News By Date | Search News

Bladder cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Sanofi Pasteur (SASY.PA) Abandons Bladder Cancer Drug     11/18/2016
Study Stopped Early as Merck & Co. (MRK)'s Immunotherapy Drug Wows in Bladder Cancer Trial     10/27/2016
Spectrum Pharma (SPPI) Allegedly Hid a Key Detail From a Meeting With the FDA     9/19/2016
Bristol-Myers Squibb (BMY)'s Miracle Drug Opdivo Receives Yet Another Breakthrough Designation     6/28/2016
ASCO2016: Genentech (RHHBY)'s TECENTRIQ Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer     6/6/2016
Genentech (RHHBY) Nabs FDA Approval of First New Bladder Cancer Drug in 30 Years     5/20/2016
Roche (RHHBY)'s Pharma Head Believes Its First Cancer Immunotherapy Will Win FDA Approval Soon     4/19/2016
Genentech (RHHBY)'s Bladder Cancer Drug Gains Priority Review by the FDA     3/16/2016
AstraZeneca PLC (AZN) Continues Its Immuno-Oncology Roll, Durvalumab Gets Breathrough Designation for Bladder Cancer     2/18/2016
FDA Lifts Heat Biologics Partial Clinical Hold     2/10/2016
Roche (RHHBY) Encouraged by Mid-Stage Atezolizumab Bladder Cancer Data     1/8/2016
Merck KGaA (MKGAF.PK), Pfizer (PFE) Accelerate Immuno-Oncology Drug Avelumab into Phase III Ovarian and Bladder Cancer Trials     12/22/2015
FDA Panel Rejects Telesta (TSX:TST)'s Bladder Cancer Drug MCNA     11/19/2015
Telesta (TSX:TST), Ipsen (IPN.PA) Strike $137 Million+ Bladder Cancer Pact     10/28/2015
Telesta (TSX:TST) Sets Up U.S. Ops in Anticipation of Approval of Bladder Cancer Drug MCNA     9/15/2015

News from Around the Web
Coroner Alarmed By Lack Of Warning On Pfizer (PFE) Drug Champix     11/21/2016
Mycobacterium In Olive Oil For Cancer Treatment, Universitat Autònoma de Barcelona Study     6/23/2016
Newcastle University Study Could Lead To Approval Of Test For Bladder Cancer     1/18/2016
No Link Found Between Bladder Cancer And Popular Diabetes Meds, University of Dundee Study     12/8/2014
Source Of Most Cases Of Invasive Bladder Cancer Identified, Stanford University School of Medicine Study     4/22/2014
Three of Four Cases of Bladder Cancer Display Mutations in the Same Gene, National Cancer Research Centre Study     9/11/2013
High Levels of Vitamin D in Plasma Protects Against Bladder Cancer, Spanish National Cancer Research Centre Study     10/31/2012
Selenium May Protect Against Bladder Cancer, Study Published in Cancer Epidemiology, Biomarkers & Prevention     9/1/2010
Well-Done Meat Doubles Bladder Cancer Risk, University of Texas Study     4/20/2010
Variation In Prostate Stem Cell Antigen Gene Raises Bladder Cancer Risk, University of Texas MD Anderson Cancer Center Study     8/20/2009
Intensive Early Treatment Doesn't Help Bladder Cancer Survival, University of Michigan Health System Study     4/8/2009
Frankincense Oil 'Could Be Alternative Treatment For Bladder Cancer', University of Oklahoma Study     3/19/2009
Investigational Treatment for Deadly Bladder Cancer, Developed Using New Research Model, by Columbia University Medical Center Faculty-Led Team     3/19/2009
Selenium May Prevent High Risk-Bladder Cancer, Dartmouth Medical School Study     12/8/2008
Yoghurt Can Benefit Bladder Cancer, Say Karolinska Institute Researchers     10/21/2008

Press Releases
PhotoCure: Late-Breaking Plenary Presentation At The American Urological Association 2017 Annual Meeting On Blue Light Flexible Cystoscopy With Hexaminolevinulate Phase III Study     4/26/2017
Bristol-Myers Squibb (BMY) Receives Positive CHMP Opinion Recommending Approval Of Opdivo (Nivolumab) For The Treatment Of Patients With Previously Treated Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer     4/24/2017
NYU Langone Medical Center Research Leads To Accelerated Approval Of Bladder Cancer Immunotherapy Drug     4/21/2017
Hoffmann-La Roche AG Release: Health Canada Approves TECENTRIQ (Atezolizumab) For Patients With Locally Advanced And Metastatic Bladder Cancer     4/18/2017
Genentech (RHHBY)'s Advanced Bladder Cancer Drug Tecentriq Wins Accelerated Approval From the FDA     4/18/2017
Celsion (CLSN) Reports Preclinical Results Of ThermoDox For The Treatment Of Bladder Cancer Published In The International Journal Of Hyperthermia     4/13/2017
Pacific Edge Release: Cxbladder Monitor Significantly Outperforms All Compared FDA Approved Urine Tests For Bladder Cancer; Enhancing The Standard Of Care For Bladder Cancer Patients     4/12/2017
bene-Arzneimittel Receives Positive CHMP Opinion For Elmiron For The Treatment Of Bladder Pain Syndrome In The European Union     4/3/2017
Asieris Pharma Doses First Patient In China Bladder Cancer Trial     4/3/2017
Bay Area's BioClin Therapeutics Nabs $30 Million Series B for Bladder Cancer Med     3/22/2017
Bavarian Nordic (BAVA.CO) Announces Collaboration To Evaluate CV301 And Tecentriq In Bladder Cancer     3/10/2017
OncoGenex (OGXI) Announces Phase II Apatorsen Data For Two Clinical Trials Presented At The OncoGenex (OGXI) 2017 Genitourinary Cancers Symposium     2/21/2017
AstraZeneca PLC (AZN) Release: Updated Durvalumab Monotherapy Data Confirm Results In Urothelial Bladder Cancer     2/17/2017
Heat Biologics Presents Immune Data On Its HS-410 Phase II Bladder Cancer Trial At The Genitourinary Cancers Symposium     2/17/2017
Bristol-Myers Squibb (BMY) Receives FDA Approval For Opdivo (Nivolumab) In Previously Treated Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer     2/3/2017

//-->